GovWire

A review into the sports supplement industry ahead of the Rio 2016 Olympic games shows the sport supplement industry is improving.

The Medicines and Healthcare products Regulatory Agency invites interested parties to provide feedback on Clinical Trial Regulation guidance documents.

MHRA has produced draft GxP data integrity guidance for industry and we welcome your comments

Web-RADR: Recognising Adverse Drug Reactions is running a survey for healthcare providers, patients, and consumers of medicines to help develop the next generation of online side-effect reporting software.

The Agency's response to the outcome of the EU referendum.

Part of the work of the medicines and medical device regulator involves looking at existing research to help reach conclusions about potential and emerging issues with devices.

MHRA has produced draft guidance for medical devices including drug-device combination products and we welcome your comments

The Medicines and Healthcare products Regulatory Agency (MHRA) is investigating an issue involving a digital calculator used by some GPs to assess the potential risk of heart disease in patients.

The MHRA-led WEB-RADR project held its General Assembly in London on April 21

MHRA issue letter to the editor of the Sunday Post in response to ‘Deadly toll of dodgy NHS gear. Thousands killed or seriously injured by faulty equipment’ article.

The WHO has declared Zika a "public health emergency of international concern." MHRA is part of the global coalition responding to the outbreak.

The Agency is holding a second public session of its board meeting. Register now to attend the meeting in April.

MHRA are making improvements to the change of ownership application (COA) process for medicines marketing authorisations (MA).

New rules approved by the European Parliament will require safety features on the packaging of medicines at risk of falsification

4 May 2016: Conference on accelerated development and access to innovative medicines for patients.

MHRA has launched a campaign highlighting the work of pharmaceutical assessors and the role they play in protecting public health.

MHRA investigators seize more than 28,000 unlicensed slimming pills in Manchester area.

Scientists at the National Institute for Biological Standards and Control (NIBSC) dispel some of the common myths about flu vaccines.

The agency will pilot holding board meetings in public in 2016.

2 March 2016: joint MHRA and ABPI training event

CPRD is planning to redevelop its website and is looking for feedback on how the current website is used.

These modules are now available online through the National Association of Medical Device Educators and Trainers (NAMDET).

8 February 2016: conference for medical device safety officers (MDSO) and medication safety officers (MSO) to explore key themes in patient safety.

Looking back at what the Medicines and Healthcare products Regulatory Agency has achieved over the last year.

Payment details for MHRA bank account will change from 18 January.

Patients with advanced melanoma are among the first in the world to access pembrolizumab through the early access to medicines scheme (EAMS).

23 February 2016: registration now open for hot topics seminar covering key topics on advertising and promotion.

1 to 5 February 2016: This 5-day course will cover European clinical pre and post-Marketing safety regulatory requirements.